(A) Representative time-courses (top) and sample traces (bottom) of spontaneous action potentials (APs) recorded from rabbit SAN cells in control conditions and in the presence of TMYX (2 and 6 …
Quantification and statistics of TMYX effect on spontaneous activity (APs) recorded from single sinoatrial node cells.
(A) Representative whole-cell currents elicited by a double-step protocol (–65 mV/1.5 s and –125 mV/0.5 s; holding potential –35 mV) before (control) and during drug (TMYX 6 mg/ml) perfusion. (B) …
Quantification and statistics of TMYX (6 mg/ml) effect on the voltage-dependence and fully-activated I/V properties of the funny current.
(A) Representative whole-cell currents (bottom) elicited by a double-step protocol (top, –65 mV/1.5 s and –125 mV/0.5 s from a holding potential of –35 mV) in control condition and during TMYX (2 …
Quantification and statistics of TMYX (2 mg/ml) effect on the voltage-dependence and fully-activated I/V properties of the funny current.
Left: Mean ± SEM steady-state current/voltage relation obtained from n = 7 cells in control (filled circles) and during TMYX perfusion (empty circles). Currents were elicited by a train of eight …
Quantification of TMYX (6 mg/ml) effect on the voltage-dependence of the steady-state funny current.
(A) Representative sample current traces recorded during steps to –65 mV in the presence and in the absence of TMYX (6 mg/ml, top) and acetylcholine (ACh) (1 µM, bottom) delivered alone (left) or in …
Quantification and statistics of TMYX (6 mg/ml) effect on rate and on the funny current amplitude in the presence and in the absence of muscarinic block.
(A) Representative steady-state time-courses (top) and sample current traces (bottom) recorded at –65 mV for 2.75 s (holding potential, –35 mV) in control condition and in the presence of TMYX (6 …
Quantification and statistics of TMYX (6 mg/ml) effect on the funny current in the presence and in the absence of the adenosine receptor block.
(A) Representative sample traces of spontaneous action potentials (APs) showing the effect of TMYX (2 mg/ml) in control condition (left) and in the presence of the PKA blocker H-89 (1 µM, right). (B)…
Quantification and statistics of TMYX (2 mg/ml) effect on APs in the presence of the PKA blocker H-89.
(A) Representative time-courses (left) of the steady-state amplitudes of the current recorded at –65 mV/2.75 s (sample traces, right) in control conditions and in the presence of TMYX (6 mg/ml). …
Quantification and statistics of TMYX (6 mg/ml) effects on the funny current in the presence of different cAMP concentrations.
(A) The bar-graph illustrates the effects of TMYX (6 mg/ml) on the whole-cell If current (elicited at –65 mV) assessed in basal condition, in the presence of the phosphodiesterase inhibitor …
Quantification and statistics of TMYX (2 mg/ml) effects on the funny current in the presence of increasing cAMP concentrations.
(A) Sample time-courses (left) and current traces (right) of If amplitudes recorded in inside-out macropatches during hyperpolarizing steps (–105 mV); cAMP (1, 10, 100 µM, n = 4–6) was perfused …
Quantification of the TMYX (6 mg/ml) ability to antagonize the cAMP-induced (dose-response) modulation of the funny current.
(A) Representative If current traces recorded from an inside-out macropatch at a voltage of –105 mV (holding potential, –35 mV) in control condition and in the presence of TMYX (6 mg/ml). The same …
Quantification and statistics of TMYX (6 mg/ml) effects on the intrinsic voltage dependence and maximal conductance of the funny current.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Oryctolagus cuniculus) | New Zealand rabbit | Charles River | Female, 35–41 days | |
Chemical compound, drug | Acetylcholine chloride (ACh) | Sigma-Aldrich (Merck) | A6625 | |
Chemical compound, drug | Adenosine 3′,5′-cyclic monophosphate sodium salt monohydrate (cAMP) | Sigma-Aldrich (Merck) | A6885 | |
Chemical compound, drug | Forskolin | Sigma-Aldrich (Merck) | F6886 | |
Chemical compound, drug | 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX) | Sigma-Aldrich (Merck) | C101 | |
Chemical compound, drug | 3-Isobutyl-1-methylxanthine (IBMX) | Sigma-Aldrich (Merck) | I5879 | |
Chemical compound, drug | H-89 dihydrochloride hydrate (H-89) | Sigma-Aldrich (Merck) | B1427 | |
Software, algorithm | pClamp – Clampfit | Molecular Devices | RRID:SCR_011323 | |
Software, algorithm | pClamp – Clampex | Molecular Devices | RRID:SCR_011323 | Version 10.7 |
Software, algorithm | Origin | Origin Lab | RRID:SCR_014212 | OriginPro 2020 |
Software, algorithm | Prism | GraphPad Software | RRID:SCR_002798 | Version 5 |
Other | Tongmai Yangxin | Le Ren Tang Pharmaceutical Factory |